Delivery Order SPE2DB20D3103-SPE2DB25FN0B3

Award Date 3/10/25
Potential Completion Date 3/11/25
Potential Value $5.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,659.26, is a Delivery Order that covers the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product. The contract has a Firm Fixed Price pricing type and an ultimate completion date of November 20, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,989.50 firm-fixed-price delivery order is for the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product. The contract has an ultimate completion date of August 31, 2022. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,488.20, is a delivery order for the supply of 4558370902 - MULTIHANCE 529 MG/ML VIAL 10ML. The contract has a firm fixed price and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which also...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $2,866.50, is for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML, a medical supply product. The contract is a Delivery Order type with a Firm Fixed Price pricing arrangement, and has an ultimate completion date of June 11, 2024. Amerisourcebergen Drug Corp's Corporate Office Division, which...
This federal contract award is for the delivery of pharmaceutical products, specifically the medication Multihance 529 mg/ml vial 10ml, to the Defense Logistics Agency (DLA) for a total ceiling value of $3,054.00. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop...
This federal contract award is for the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,989.50 firm-fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves to provide a wide range of pharmaceutical...
This federal contract award is from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $3,993.80, is for the delivery of MULTIHANCE 529MG/ML 5S, a medical product. The contract has an ultimate completion date of March 29, 2024 and was awarded on March 4, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of MULTIHANCE 529MG/ML 5S medical supplies from the prime contractor, Amerisourcebergen Drug Corp, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $13,382.60 and an ultimate completion date of November 7, 2023. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. This...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order (SPE2DB23FL4S7) for the pharmaceutical product MULTIHANCE 529 MG/ML VIAL 20ML, valued at $3,006.75. The contract has an ultimate completion date of October 28, 2022 and was awarded on October 27, 2022. The contracting agency is the Defense Logistics Agency (DLA), a defense agency, and the contract is a firm fixed-price delivery order with no set-aside designation. This award is associated with a larger $999,999,999...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distributor, to provide MULTIHANCE 529 MG/ML VIAL 20ML, a specialty pharmaceutical product. The delivery order has a ceiling value of $1,189.20 and a period of performance through April 5, 2024. This award is a child contract under a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, also awarded by DLA, with a potential...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FN0B3
    Delivery Order

This federal contract award, with ID SPE2DB20D3103|SPE2DB25FN0B3, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $5,851.00, is a Firm Fixed Price Delivery Order for the procurement of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product. The contract has an ultimate completion date of March 11, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award was not designated with a set-aside requirement, indicating open competition.

Generated 6/9/25, 9:50 AM